Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

26.27
-0.2100-0.79%
Volume:19.38M
Turnover:510.65M
Market Cap:149.36B
PE:19.32
High:26.55
Open:26.36
Low:26.20
Close:26.48
52wk High:28.75
52wk Low:21.97
Shares:5.69B
Float Shares:5.68B
Volume Ratio:0.49
T/O Rate:0.34%
Dividend:1.72
Dividend Rate:6.55%
EPS(TTM):1.36
EPS(LYR):1.36
ROE:8.89%
ROA:5.68%
PB:1.73
PE(LYR):19.25

Loading ...

Earning Preview: Pfizer revenue is expected to decrease by 0.88%, and institutional views are cautiously bullish

Earnings Agent
·
Apr 28

Pfizer Is Maintained at Neutral by Citigroup

Dow Jones
·
1 hour ago

Pfizer's blood cancer drug meets main goal in late-stage trial

Reuters
·
Yesterday

Pfizer price target raised to $27 from $26 at Citi

TIPRANKS
·
Yesterday

Pfizer says Phase 3 MagnetisMM-5 trial meets primary endpoint for ELREXFIO in myeloma

Reuters
·
Yesterday

Pfizer - Elrexfio Demonstrates Superior Progression-Free Survival Versus Standard-of-Care Dpd

THOMSON REUTERS
·
Yesterday

Pfizer - No New Safety Signals Identified for Elrexfio in Magnetismm-5 Trial

THOMSON REUTERS
·
Yesterday

Pfizer - Magnetismm-5 Trial Meets Primary Endpoint at Interim Analysis

THOMSON REUTERS
·
Yesterday

Pfizer’s Elrexfio Significantly Improves Progression-Free Survival for Double-Class Exposed Patients With Relapsed or Refractory Multiple Myeloma

THOMSON REUTERS
·
Yesterday

Pfizer - Magnetismm-5 Trial Ongoing to Assess Overall Survival

THOMSON REUTERS
·
Yesterday

GSK shares slide as investors question one-off result boost

Reuters
·
Yesterday

Pfizer : Jefferies Raises Target Price to $35 From $34

THOMSON REUTERS
·
Yesterday

Pfizer Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Yesterday

Jefferies Adjusts Price Target on Pfizer to $35 From $34, Maintains Buy Rating

MT Newswires Live
·
Yesterday

BUZZ-BridgeBio slips as Pfizer patent deal disappoints investors

Reuters
·
Yesterday

Analysts Have Conflicting Sentiments on These Healthcare Companies: Phathom Pharmaceuticals (PHAT), Pfizer (PFE) and Guardant Health (GH)

TIPRANKS
·
Apr 28

BridgeBio turns negative after Pfizer details tamidis settlement

TIPRANKS
·
Apr 28

BridgeBio jumps 12% to $83.18 as Pfizer confirms tafamidis settlement

TIPRANKS
·
Apr 28

Pfizer announces three settlement agreements for Vyndamax

TIPRANKS
·
Apr 28

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Reuters
·
Apr 28